HOME >> MEDICINE >> NEWS
Pharmaceutical Achievers

JUST PUBLISHED! Pharmaceutical Achievers by Mary Ellen Bowden, Amy Beth Crow, and Tracy Sullivan This biographical collection highlights individuals who made outstanding achievements in the arenas of pharmaceuticals and biotechnology.

Pharmaceutical Achievers presents chronologically the major directions of pharmaceutical research and, in their historical context, the breakthroughs in treating various diseases. It concludes with a look at tomorrow's medicines. This work is particularly useful in the classroom, where its accounts of challenges and triumphs may inspire students to consider careers that support pharmaceutical research and development. 2003. xii + 214 pp, bibl, index Paper, 8.5 11, ISBN 0-941901-30-0 $30.00 (Teachers: Ship to your school's address and pay only $15.00.)

Pharmaceutical Achievers Modules In conjunction with Pharmaceutical Achievers, CHF's Beckman Center for the History of Chemistry has created a series of online educational modules. The modules, which include such topics as "Aspirin Adventures" and "Antibiotics in Action", contain readings, laboratory and pencil-and-paper activities, and instructions for teachers on using them in the classroom. Free Access Online! Visit www.chemheritage.org-click on "Educational Services" and follow the links!


'"/>

Contact: Greg November
gregn@chemheritage.org
215-925-2222
Chemical Heritage Foundation
1-Apr-2003


Page: 1

Related medicine news :

1. Pharmaceutical marketing tactics hold little sway with prescribing physicians
2. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
3. Pharmaceutical industry still failing health needs of less-developed countries
4. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
5. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
6. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
7. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
8. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
9. Pharmaceuticals and personal care products
10. New publisher announced for Journal Of Pharmaceutical Sciences
11. American Association of Pharmaceutical Scientists tapped to manage PQRI

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pharmaceutical Achievers

(Date:10/31/2014)... for low back pain caused by spinal stenosis varies ... a new report says. "Nearly 80 percent of ... in their lives, and about 30 million people a ... co-author Brook Martin, of the Dartmouth Institute of Health ... release. In spinal stenosis, thickening of tissue surrounding ...
(Date:10/31/2014)... IL – New research suggests that insomnia is a ... and other unintentional fatal injuries. The results underscore the ... the National Healthy Sleep Awareness Project. , Results show ... a dose-dependent manner with the number of insomnia symptoms ... 2.8 times more likely to die from a fatal ...
(Date:10/31/2014)... The Suspension Revolution review published by Daily Gossip ... Dan Long, a suspension training specialist. , Long ... life coach. The author of this program claims that ... impossible , The Suspension Revolution review reveals that this ... efficiency when it comes to burning fat, building muscles, ...
(Date:10/31/2014)... Florida Air Academy, the Melbourne ... grades 6-12, is taking the lead when it ... concussions, becoming the first high school in central ... Assessment and Cognitive Testing) computerized assessment to all ... grabs the headlines, and the Centers for Disease ...
(Date:10/31/2014)... Phoenix dentist , Dr. Christy, is ... Whether patients simply need routine care or have a more ... now to get that necessary care. The right dental treatments ... and even essential treatments due to financial concerns. Throughout the ... any treatments offered by the team at Christy Dental Care. ...
Breaking Medicine News(10 mins):Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2
(Date:10/31/2014)... 31, 2014 Mast Therapeutics, Inc. (NYSE MKT: ... for the quarter ended September 30, 2014. ... said:  "The third quarter was productive for Mast. Consistent with ... MST-188 for sickle cell disease is on track to ... have opened 50 study sites in the U.S. and ...
(Date:10/31/2014)... ARBOR, Mich. , Oct. 31, 2014 /PRNewswire/ ... immune modulators to treat autoimmune disease and cancer, ... of novel synthetic RORgamma agonist product candidates will ... Society for Immunotherapy of Cancer (SITC) being held ... & Convention Center, National Harbor, MD.  The poster, ...
(Date:10/31/2014)... 31, 2014 ThynkWare ( www.thynkware.com ) is ... text and email messages using their thoughts. ... by ThynkWare,s founder, Duane Cash , which is ... This technology allows users to control their devices in ... thought. ThynkWare provides the interface layer between ...
Breaking Medicine Technology:Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2
Cached News: